Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s) and Portfolio Update

7 Feb 2019 07:00

RNS Number : 3119P
CATCo Reinsurance Opps Fund Ltd
07 February 2019
 

FOR IMMEDIATE RELEASE

 

 

7 February 2019

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

Net Asset Value ("NAV" and Portfolio Update)

To: SFS, London Stock Exchange and Bermuda Stock Exchange

Markel CATCo Investment Management Ltd., as Investment Manager (the "Manager"), announces the unaudited net asset value of the Company's Ordinary Shares and C Shares of $0.3479 and $0.6299 respectively, as at the close of business on 31 December 2018.

 

As previously announced the Company's Ordinary Shareholders continue to be exposed to uncertainty regarding losses arising from 2017 major events through the 2017 Side Pocket Investments.

 

Using the latest claim information from cedents and trend analysis of paid losses for hurricanes Harvey, Irma and Maria, the Manager has determined to increase the specific loss reserves recorded in relation to the 2017 Side Pocket Investments.

 

The result of this increase is to reduce the 30 November 2018 Ordinary Share NAV by 13 per cent. On a normalised basis, this represents approximately a four per cent deterioration in the Ordinary Share 2017 annual performance and is equivalent to a 2017 NAV return on the Ordinary Shares of approximately -61 per cent (down from the -57.1 per cent previously reported).

 

With regard to loss reserving for 2018 catastrophe events, the 31 December 2018 review process has confirmed that existing loss reserves are deemed sufficient based on latest industry loss information.

 

Overview of existing Side Pocket Investments

Shareholders are reminded that the maximum exposure to previous events is ring-fenced in Side Pocket Investments. Losses cannot exceed the remaining NAV held within that Side Pocket. The following table outlines the split of Side Pocket Investments held by the Ordinary Shares and C Shares respectively as at 31 December 2018:

 

Ordinary Shares

Value

Side Pocket Investments

 

 

% of Ordinary Share NAV

SPI 2015

$0.01

2%

SPI 2016

$0.03

11%

SPI 2017

$0.15

42%

SPI 2018

$0.07

21%

 

C Shares

Value

Side Pocket Investments

 

 

% of C Share NAV

SPI 2018

$0.30

47%

 

 

Redemption Share Proposal

 

Further to the announcement on 18 December 2018, in which the Board announced the intention to offer shareholders the option to convert their shareholdings into redemption shares, the Board is now seeking feedback on whether shareholders would prefer to either elect to convert their holdings into redemption shares or continue to hold either ongoing Ordinary or C Shares. Shareholders are requested to contact Numis Securities to provide feedback as to a preference to elect for either the redemption opportunity or continution share class.

 

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

 

For further information:

 

Markel CATCo Investment Management Ltd.

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief of Investor Marketing

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

Numis Securities Limited

 

David Benda / Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVEAAAKESENEAF
Date   Source Headline
30th Jun 20064:12 pmRNSHolding(s) in Company
30th Jun 20064:06 pmRNSDelisting
30th Jun 200610:27 amRNSAdditional Listing
30th Jun 20067:02 amRNSOffer for Cambridge Antibody
27th Jun 20062:26 pmRNSHolding(s) in Company
27th Jun 200612:34 pmRNSHolding(s) in Company
23rd Jun 20062:25 pmRNSAppointment of Directors
22nd Jun 20063:07 pmRNSRule 8.3- CAT
22nd Jun 200611:31 amRNSCAT Limited appoints new CE
22nd Jun 200611:11 amRNSEPT Disclosure
22nd Jun 200611:09 amRNSEPT Disclosure
22nd Jun 20067:02 amRNSOffer for Cambridge Antibody
21st Jun 20065:11 pmRNSRule 8.1- C.A.T.
21st Jun 200611:30 amRNSEPT Disclosure
21st Jun 200610:20 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
19th Jun 20063:25 pmRNSRule 8.3 - Cambridge Antibody
19th Jun 20061:07 pmRNSRule 8.3- (CAT)
19th Jun 200611:30 amRNSEPT Disclosure
19th Jun 200611:23 amRNSEPT Disclosure
19th Jun 200610:33 amRNSEPT Disclosure
16th Jun 200611:45 amRNSEPT Disclosure
16th Jun 200611:24 amRNSEPT Disclosure
16th Jun 200611:08 amRNSEPT Disclosure
15th Jun 20065:01 pmRNSEPT Disclosure
15th Jun 20062:48 pmRNSRule 8.3- (CAT)
15th Jun 20062:17 pmRNSRule 2.10 Announcement
15th Jun 200612:45 pmRNSEPT Disclosure
15th Jun 200611:36 amRNSEPT Disclosure
14th Jun 20063:38 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20063:05 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20061:43 pmRNSRule 8.3- (CAT)
14th Jun 200611:36 amRNSEPT Disclosure
14th Jun 200611:15 amRNSEPT Disclosure
14th Jun 200610:59 amRNSEPT Disclosure
14th Jun 200610:23 amRNSEPT Disclosure
13th Jun 20064:50 pmRNSRule 8.3- Cambridge Antibody
13th Jun 20063:54 pmRNSRule 2.10 Announcement
13th Jun 200612:18 pmRNSEPT Disclosure
13th Jun 200611:42 amRNSEPT Disclosure
13th Jun 200611:35 amRNSEPT Disclosure
13th Jun 200610:20 amRNSEPT Disclosure
12th Jun 20065:35 pmRNSRule 8.3 - Cambridge Antibody
12th Jun 200612:00 pmRNSEPT Disclosure
12th Jun 200611:34 amRNSEPT Disclosure
12th Jun 200611:14 amRNSRule 8.3- (CAT)
12th Jun 200610:08 amRNSEPT Disclosure
12th Jun 20067:00 amRNSRule 8.3- Cambridge Antibody
9th Jun 20061:30 pmRNSRule 8.3- (CAT)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.